PanTheryx makes medical foods and treatments for gastrointestinal infections and bases those products on colostrum, the first milk produced by mammals after they give birth. Newborn animals need colostrum to gain passive immunity to disease.

The company last landed a $50 million investment from New York-based investment firm Perceptive Partners in June. CEO Mark Braman previously told BizWest the company plans to start clinical trials of its medicinal foods candidates with the U.S. Food and Drug Administration by the end of the year, and to have biologic treatments in trials by Q1 2020.

Investments in on-site solar energy can increase cash flow, NOI and property value – all with $0 out of pocket and over 50 percent in tax benefits. And, corporate tax structures allow 100 percent depreciation in the first year. Here are a few key considerations when evaluating solar.

PanTheryx makes medical foods and treatments for gastrointestinal infections and bases those products on colostrum, the first milk produced by mammals after they give birth. Newborn animals need colostrum to gain passive immunity to disease.

The company last landed a $50 million investment from New York-based investment firm Perceptive Partners in June. CEO Mark Braman previously told BizWest the company plans to start clinical trials of its medicinal foods candidates with the U.S. Food and Drug Administration by the end of the year, and to have biologic treatments in trials by Q1 2020.